FDA Proposes New Tobacco Product Establishment Registration and Product Listing Requirements, Extending to Foreign Entities

What this means for your practice

This proposed rule primarily targets owners and operators of establishments involved in the manufacturing, preparation, propagation, compounding, or processing of tobacco products, or those who import such products. For the vast majority of telehealth brands, medspas, dental practices, and chiropractic offices, this regulation will have no direct operational impact, as these entities typically do not engage in the production or listing of tobacco products. Healthcare businesses with ancillary involvement in the manufacturing or distribution of tobacco products, however, should review these proposed requirements closely, especially if operating internationally.

Washington D.C. — The Food and Drug Administration (FDA) has announced a proposed rule aimed at enhancing public health oversight by standardizing and expanding requirements for the registration of tobacco product establishments and the listing of tobacco products. This action, if finalized, would extend these critical regulatory obligations to foreign establishments, closing a significant gap in the Agency's current information.

Overview of the Proposed Rule

The FDA, under the Department of Health and Human Services (HHS), is proposing new regulations, designated under 21 CFR Part 1108, to prescribe the format, content, and procedures for submitting establishment registration and tobacco product listing information. The Agency emphasizes that complete and accurate data on tobacco product establishments and their listed products are vital for achieving statutory, regulatory, and public health objectives.

Currently, only domestic owners and operators of tobacco product establishments are mandated to register their facilities and list their tobacco products with the FDA. This existing framework means that foreign owners and operators are not subject to these same requirements, leading to what the FDA identifies as substantial information gaps critical to effective regulation and public health protection. The proposed rule directly addresses this disparity by extending these requirements to include owners and operators of foreign establishments involved in tobacco product manufacturing or processing.

Rationale for the Expansion

The expansion of registration and listing requirements to foreign establishments is intended to provide the FDA with a more comprehensive understanding of the global tobacco product market that impacts U.S. consumers. By requiring foreign entities to register and list their products, the Agency aims to improve its ability to:

• Monitor the types and quantities of tobacco products being manufactured globally.
• Identify establishments producing tobacco products, regardless of their geographic location.
• Enhance surveillance and enforcement capabilities regarding imported tobacco products.
• Better assess potential public health risks associated with tobacco products entering the U.S. market.

This move aligns with broader efforts by federal agencies to ensure parity in regulatory oversight between domestic and international entities whose products are distributed within the United States.

Comment Period and Submission Details

The FDA encourages stakeholders, including industry members, public health organizations, and interested individuals, to submit comments on this proposed rule. Both electronic and written comments must be submitted by September 14, 2026.

Electronic Submissions: Comments can be submitted via the Federal eRulemaking Portal at https://www.regulations.gov. Filers should follow the instructions provided on the portal and include Docket No. FDA-2025-N-7130. It is important to note that electronic comments, including attachments, will be publicly posted unchanged. Therefore, commenters are responsible for ensuring no confidential information, such as medical data, Social Security numbers, or confidential business information, is included in their public submission.

Written/Paper Submissions: Written comments can be mailed or hand-delivered to Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. For those wishing to submit confidential information, specific instructions must be followed, including submitting two copies, one with the confidential information clearly marked and a second redacted copy for public viewing. Any information marked as “confidential” will be handled in accordance with 21 CFR 10.20 and other applicable disclosure laws.

All submissions must reference Docket No. FDA-2025-N-7130. Timely received comments will be placed in the public docket and will be viewable online or at the Dockets Management Staff office.

Key Facts

| Detail | Value | |---|---| | Agency | Food and Drug Administration (FDA), HHS | | Action | Proposed Rule | | CFR Part Affected | 21 CFR Part 1108 | | Docket Number | FDA-2025-N-7130 | | RIN | 0910-AH59 | | Comment Deadline | September 14, 2026 |

Frequently Asked Questions

What is the primary goal of this proposed FDA rule?

The primary goal is to prescribe the format, content, and procedures for establishment registration and tobacco product listing, and to extend these requirements to include owners and operators of foreign establishments.

Who is currently required to register their establishments and list tobacco products with the FDA?

Currently, only domestic owners and operators are required to register their establishments and list their tobacco products with the FDA.

How does this proposed rule change the existing requirements?

If finalized, this action would extend registration and listing requirements to include owners and operators of foreign establishments, which are not currently subject to these rules.

When is the deadline for submitting comments on this proposed rule?

Electronic or written comments on the proposed rule must be submitted by September 14, 2026.

Where can I submit comments on the proposed rule?

Comments can be submitted electronically via the Federal eRulemaking Portal at https://www.regulations.gov or by mail/hand delivery to Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

Source: FDA — Proposed Rule: Establishment Registration and Product Listing for Tobacco Products · 2026-06-29